Scolaris Content Display Scolaris Content Display

여성의 분만 입원시 간헐적 모니터링과 분만 감시 장치 (CTG)에 의한 태아 심장의 전자 모니터링 비교

Contraer todo Desplegar todo

Referencias

References to studies included in this review

Cheyne 2003 {published data only}

Cheyne H, Dunlop A, Shields N, Mathers AM. A randomised controlled trial of admission electronic fetal monitoring in normal labour. Midwifery 2003;19(3):221‐9. CENTRAL

Impey 2003 {published data only}

Impey L, Reynolds M, MacQuillan K, Gates S, Murphy J, Sheil O. Admission cardiotocography: a randomised controlled trial. Lancet 2003;361(9356):465‐70. CENTRAL

Mires 2001 {published data only}

Mires G, Williams F, Howie P. Randomised controlled trial of cardiotocography versus doppler auscultation of fetal heart at admission in labour in low risk obstetric population. BMJ 2001;322(7300):1457‐60. CENTRAL
Mires GJ, Williams FLR, Howie PW. Randomised controlled trial of cardiotocography versus doppler auscultation of the fetal heart at admission in labour in a low risk obstetric population [abstract]. Journal of Perinatal Medicine 2001;29 Suppl 1(Pt 2):295. CENTRAL

Mitchell 2008 {published data only}

ISRCTN28370122. A randomised controlled trial evaluating the relationship between the labour electronic fetal monitoring (EFM) admission test and obstetric intervention in low risk mothers. isrctn.com/ISRCTN28370122 Date first received: 12 September 2003. CENTRAL
Mitchell K. The effect of the labour electronic fetal monitoring admission test on operative delivery in low‐risk women: a randomised controlled trial. Evidence Based Midwifery 2008;6(1):18‐26. CENTRAL

Devane 2008 {published data only}

ISRCTN96340041. A randomised controlled trial comparing the effect of admission cardiotocography versus intermittent auscultation of the foetal heart rate on low‐risk women on admission to labour ward showing signs of possible labour. isrctn.com/ISRCTN96340041 Date first received: 25 March 2008. CENTRAL

Alfirevic 2013

Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in high‐risk pregnancies. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD007529]

Arulkumaran 2000

Arulkumaran S, Jenkins HML. Perinatal Asphyxia. Chennai: Orient Longman Ltd, 2000.

Ayres‐de‐Campos 2015

Ayres‐de‐Campos D, Spong CY, Chandraharan E. FIGO consensus guidelines on intrapartum fetal monitoring: Cardiotocography. International Journal of Gynaecology and Obstetrics 2015;131(1):13‐24.

Bayley 1993

Bayley N. Manual for the Bayley Scales of Infant Development. 2nd Edition. San Antonio: The Psychological Corporation, 1993.

Brown 2008

Brown HC, Paranjothy S, Dowswell T, Thomas J. Package of care for active management in labour for reducing caesarean section rates in low‐risk women. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD004907.pub2]

Caldeyro‐Barcia 1966

Caldeyro‐Barcia R, Mendez‐Bauer C, Poseiro JJ, Escarcena LA, Pose SV, Bieniarz J, et al. Control of human fetal heart rate during labour. In: Cassels DE editor(s). The Heart and Circulation in the Newborn and Infant. New York: Grune and Stratton, 1966:7‐36.

CESDI 2001

Maternal and Child Health Research Consortium. Confidential Enquiry into Stillbirths and Deaths in Infancy (CESDI): 8th Annual Report. London: Maternal and Child Health Research Consortium, 2001.

Devane 2007

Devane D, Lalor J, Bonnar J. The use of intrapartum electronic fetal heart rate monitoring: a national survey. Irish Medical Journal 2007;100(2):360‐2. [PUBMED: 17432809]

East 2013

East CE, Smyth RMD, Leader LR, Henshall NE, Colditz PB, Lau R, et al. Vibroacoustic stimulation for fetal assessment in labour in the presence of a nonreassuring fetal heart rate trace. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD004664]

Gail‐Thomas 2003

Gail‐Thomas B. The disempowering concept of risk. In: Wickham S editor(s). Midwifery Best Practice. London: Books for Midwives Press, 2003:3‐6.

Gourounti 2007

Gourounti K, Sandall J. Admission cardiotocography versus intermittent auscultation of fetal heart rate: effects on neonatal Apgar score, on the rate of Caesarean sections and on the rate of instrumental delivery. A systematic review. International Journal of Nursing Studies 2007;44(6):1029‐1035.

Grivell 2012

Grivell RM, Wong L, Bhatia V. Regimens of fetal surveillance for impaired fetal growth. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: 10.1002/14651858.CD007113]

Grivell 2015

Grivell RM, Alfirevic Z, Gyte GML, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD007863]

Hammacher 1968

Hammacher K, Hūter K, Bokelmann J, Werners P. Foetal heart frequency and perinatal condition of the foetus and newborn. Gynecologica 1968;166(4):349‐60.

Higgins 2011

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Holzmann 2010

Holzmann M, Nordström L. Follow‐up national survey (Sweden) of routines for intrapartum fetal surveillance. Acta Obstetricia et Gynecologica Scandinavica 2010;89(5):712‐4.

Hon 1958

Hon EH. The electronic evaluation of the fetal heart rate; preliminary report. American Journal of Obstetrics and Gynecology 1958;75(6):1215‐30.

Kaczorowski 1998

Kaczorowski J, Levitt C, Hanvey L, Avard D, Chance G. A national survey of use of obstetric procedures and technologies in Canadian hospitals: routine or based on existing evidence?. Birth 1998;25(1):11‐8.

Lalor 2008

Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD000038.pub2]

Liston 2007

Liston R, Sawchuck D, Young D, Society of Obstetrics and Gynaecologists of Canada, British Columbia Perinatal Health Program. Fetal health surveillance: antepartum and intrapartum consensus guideline. Journal of Obstetrics and Gynaecology Canada 2007;29(9 Suppl 4):S3‐56.

MacLennan 1999

MacLennan A. A template for defining a causal relation between acute intrapartum events and cerebral palsy: international consensus statement. BMJ 1999;319(7216):1054‐9.

Mangesi 2015

Mangesi L, Hofmeyr GJ, Smith V, Smyth RMD. Fetal movement counting for assessment of fetal wellbeing. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: 10.1002/14651858.CD004909]

Nabhan 2008

Nabhan AF, Abdelmoula YA. Amniotic fluid index versus single deepest vertical pocket as a screening test for preventing adverse pregnancy outcome. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD006593.pub2]

NCCWCH 2007

National Collaborating Centre for Women’s and Children’s Health. Intrapartum Care: Care of Healthy Women and Their Babies During Childbirth. London: RCOG Press, 2007.

Neilson 2012

Neilson JP. Biochemical tests of placental function for assessment in pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD000108]

Nelson 1996

Nelson KB, Dambrosia JM, Ting TY, Grether JK. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. New England Journal of Medicine 1996;334(10):613‐8.

RANZCOG 2002

Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Clinical Guidelines: Intrapartum Surveillance. East Melbourne: RANZCOG, 2002.

RCOG 2001

Royal College of Obstetricians and Gynaecologists. The Use of Electronic Fetal Monitoring: the Use and Interpretation of Cardiotocography in Intrapartum Fetal Surveillance. Evidence‐based Clinical Guideline Number 8. London: Royal College of Obstetricians and Gynaecologists, 2001.

RevMan 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Sarnat 1976

Sarnat HB, Sarnat MS. Neonatal encephalopathy following fetal distress: a clinical and electrographic study. Archives of Neurology 1976;33(10):696‐705.

Stampalija 2010

Stampalija T, Alfirevic Z, Gyte GML. Utero‐placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database of Systematic Reviews 2010, Issue 2. [DOI: 10.1002/14651858.CD008363]

Tan 2012

Tan KH, Sabapathy A. Maternal glucose administration for facilitating tests of fetal wellbeing. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD003397]

Tan 2013a

Tan KH, Sabapathy A, Wei X. Fetal manipulation for facilitating tests of fetal wellbeing. Cochrane Database of Systematic Reviews 2013, Issue 12. [DOI: 10.1002/14651858.CD003396]

Tan 2013b

Tan KH, Smyth RMD, Wei X. Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing. Cochrane Database of Systematic Reviews 2013, Issue 12. [DOI: 10.1002/14651858.CD002963]

WHO 1999

World Health Organization. Care in Normal Birth: a Practical Guide. Report of a Technical Working Group. Geneva: World Health Organization, 1999.

References to other published versions of this review

Devane 2010

Devane D, Lalor JG, Daly S, McGuire W, Smith V. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. Cochrane Database of Systematic Reviews 2010, Issue 8. [DOI: 10.1002/14651858.CD005122.pub3]

Devane 2012

Devane D, Lalor JG, Daly S, McGuire W, Smith V. Cardiotocography versus intermittent auscultation of fetal heart on admission to labour ward for assessment of fetal wellbeing. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD005122.pub4]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Cheyne 2003

Methods

Study design: RCT.

Duration of study: 1999.

Participants

Setting: Glasgow Royal Maternity Hospital, Scotland.

Inclusion criteria: healthy women who had experienced a normal pregnancy, presented at term in spontaneous labour and were eligible for admission to the Midwives Birth Unit.
Exclusion criteria: women with risk factors.
Participants randomised: 334 women (157 admission CTG (referred to as 'control group' in paper), 177 intermittent auscultation (referred to as 'study group' in paper)).

Randomisation on admission in labour.

Interventions

Admission CTG: a routine 20‐minute period of EFM at the time of admission.

Intermittent auscultation: the fetal heart was auscultated during and immediately following a contraction for a minimum of 60 seconds.

Outcomes

Outcomes considered in the review and reported in or extracted from the study:

  • caesarean section;

  • instrumental vaginal birth;

  • continuous EFM during labour;

  • amniotomy;

  • oxytocin for augmentation of labour;

  • epidural;

  • fetal blood sampling;

  • fetal and neonatal deaths;

  • Apgar score < 7 at or after 5 minutes;

  • admission to neonatal intensive care.

Notes

Unpublished data to permit re‐inclusion of women to groups as randomised kindly provided by author.

This study was funded by North Glasgow University Hospitals NHS Trust.

Declaration of interest were not mentioned in the trial.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"...computer‐generated in order to allocate participants equally between the two groups..."

Allocation concealment (selection bias)

Low risk

"...sequentially numbered, sealed opaque envelopes, which contained allocation to the appropriate group."

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Although not documented, we judged, given nature of intervention, that women and clinicians were not blind to the interventions used.

Blinding of outcome assessment (detection bias)
All outcomes

High risk

Not blinded.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Loss to follow‐up: in the trial report 22 women (7%) are excluded from the analysis (21 women entered into the study and found not to be in labour and 1 randomisation card missing). However, data for these 21 of 22 women were identified and extracted subsequently by the trial author and kindly provided to the review team.

Selective reporting (reporting bias)

Low risk

All outcomes stated in the methods section were reported adequately in results.

Other bias

Low risk

None identified.

Impey 2003

Methods

Study design: RCT.

Duration of study: 1997 to 2001.

Participants

Setting: National Maternity Hospital in Dublin, Ireland.

Inclusion criteria: women were eligible for inclusion if they were admitted in labour, a singleton pregnancy, fewer than 42 completed weeks of gestation, no suspicion or evidence of antenatal fetal compromise, no adverse obstetric history, clear amniotic fluid, and maternal temperature of 37.5°C or less at admission.
Participants randomised: 8628 women (4320 admission CTG, 4308 intermittent auscultation).

Randomisation on admission in labour.

A relatively small number (fewer than 5%) of women who had a previous caesarean section and who went into labour prior to 37 completed weeks' gestation were included in this study and were randomised. The trial author kindly provided data separately for the outcomes for women (i) between 37 and 42 completed weeks with (ii) an absence of previous caesarean section and these data were used in the main analyses for this review. Sensitivity analyses were conducted in which the outcomes for all randomised women were used.

Interventions

Admission CTG: a 20‐minute admission CTG immediately after early amniotomy done on diagnosis of labour in women presenting to the delivery ward.

Intermittent auscultation: intermittent auscultation was used for 1 minute after a contraction every 15 minutes in the first stage and every 5 minutes in the second stage of labour. This was done after early amniotomy on diagnosis of labour in women presenting to the delivery ward.

Outcomes

Outcomes considered in the review and reported in or extracted from the study:

  • caesarean section;

  • instrumental vaginal birth;

  • continuous EFM during labour;

  • oxytocin for augmentation of labour;

  • epidural;

  • fetal blood sampling;

  • fetal and neonatal deaths;

  • Apgar score < 7 at or after 5 minutes;

  • neonatal seizures;

  • admission to neonatal intensive care;

  • length of stay in neonatal intensive care (hours).

Notes

See Participants (above)

The study was funded by the Research Committee of the National Maternity Hospital, Holles St, Dublin, Ireland.

Declarations of interest: none declared.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"...the randomisation sequence was from a commercial package 10 and used a fixed block size of 100. It was changed after 2621 patients had been recruited, and was generated by the National Perinatal Epidemiology Unit with random block sizes of 100–250."

Allocation concealment (selection bias)

Low risk

"...sealed, opaque, sequentially numbered envelope."

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Although not documented, we judged, given nature of intervention, that women and clinicians were not blind to the interventions used.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

"...Data were entered and neonatal assessment was made without knowledge of the randomised assignment."

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Loss to follow‐up = 22 (0.5%); admission CTG 26 (0.6%). Intermittent auscultation.

For outcome 'pH less than 7 or BD/E > than 12 mmol/L' 7.5% and 7.8% data missing for admission CTG and intermittent auscultation respectively.

Selective reporting (reporting bias)

Low risk

All outcomes stated in the methods section were reported adequately in results.

Other bias

Low risk

None identified.

Mires 2001

Methods

Study design: RCT.

Duration of study: not stated.

Participants

Setting: Dundee, Scotland.

Inclusion criteria: "Women were eligible to join the study if they were booked for hospital delivery, attended a hospital or community based consultant led clinic in the third trimester of pregnancy, and had no obstetric complications at that visit that would warrant continuous intrapartum monitoring of FHR (pre­ eclampsia or hypertension in previous or index pregnancy; essential hypertension; diabetes (insulin dependent or gestational); suspected intrauterine growth restriction; placental abruption or praevia or vaginal bleeding of unknown origin; multiple pregnancy; fetal malformation; previous caesarean section; breech presentation; or rhesus isoimmunisation)."
Participants randomised: 3752 women randomised. "No data collected n = 1" (1866 admission CTG, 1885 intermittent auscultation).

A total of 3752 women were recruited to the study and randomised during the third trimester. However, some women developed an obstetric complication between randomisation and admission in labour that warranted continuous FHR monitoring in labour, such that only 2367 women were judged to be low‐risk when in labour (1186 admission CTG, 1181 intermittent auscultation). The trial author kindly provided data separately for the outcomes in this subgroup of women and these data are used in the main analyses in this review. Sensitivity analyses were done in which the outcomes for all randomised women were used.

Interventions

Admission CTG: a 20‐minute CTG on admission in spontaneous uncomplicated labour.

Intermittent auscultation: auscultation of the fetal heart with a hand‐held Doppler device during and immediately after at least 1 contraction.

Outcomes

Outcomes considered in the review and reported in or extracted from the study:

  • caesarean section;

  • instrumental vaginal birth;

  • continuous EFM during labour;

  • amniotomy;

  • oxytocin for augmentation of labour;

  • epidural;

  • fetal blood sampling;

  • fetal and neonatal deaths;

  • evidence of fetal multi‐organ compromise within the first 24 hours after birth;

  • Apgar score < 7 at or after 5 minutes;

  • hypoxic ischaemic encephalopathy;

  • admission to neonatal intensive care;

  • length of stay in neonatal intensive care (days).

Notes

See Participants (above)

This study was funded by Chief Scientists Office of the Scottish Executive, Edinburgh.

Declarations of interest: none declared.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"...commercially available computer randomisation program."

Allocation concealment (selection bias)

Low risk

"The allocation was placed in a sealed envelope..."

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Although not documented, we judged, given nature of intervention, that women and clinicians were not blind to the interventions used.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

"The data analysts were blind to the randomisation code."

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Loss to follow‐up for the primary outcome of metabolic acidosis was high (admission CTG N = 310, 26% and intermittent auscultation N = 321, 27%). However, metabolic acidosis was defined as "pH less than 7.20 or BD (Base Deficit) > than 8 mmol/L". Data were unavailable for the outcome metabolic acidosis as defined in this review, i.e. 'pH less than 7 or BD/E > than 12 mmol/L', therefore this study does not provide data for this outcome in this review. All other outcomes had low rates of missing data, hence rating as low risk of bias.

Selective reporting (reporting bias)

Low risk

All outcomes stated in the methods section were reported adequately in results.

Other bias

Low risk

"Between randomisation during the third trimester of pregnancy and admission in labour, 1384 women (37%) developed an obstetric complication that warranted continuous fetal heart rate monitoring in labour".

A total of 3752 women were recruited to the study and randomised during the third trimester. However, some women developed complications between randomisation and admission in labour, such that only 2367 women were judged to be low risk when in labour (1186 admission CTG, 1181 intermittent auscultation). There are similar levels of attrition in both groups due to development of complications suggesting that allocation concealment remained intact. The trial author kindly provided data separately for the outcomes in this low‐risk subgroup of women and these data are used in the main analyses in this review.

Mitchell 2008

Methods

Study design: RCT.

Duration of study: 2002 to 2006.

Participants

Setting: Buckinghamshire, England.

Inclusion criteria: labouring women considered to be "low risk" of fetal or maternal complications on admission.

Exclusion criteria: any minor maternal medical complication, e.g. diabetes or essential hypertension; previous caesarean section; preterm labour (< 37 completed weeks); multiple pregnancy; prolonged pregnancy (> 42 completed weeks); prolonged membrane rupture (more than 24 hours); induction of labour; meconium‐stained liquor; maternal pyrexia; rhesus sensitisation; polyhydramnios; oligohydramnios; pre‐eclampsia or blood pressure over 140/90 mmHg; abnormal presentation or lie (e.g. breech, transverse); high head (5/5ths palpable per abdomen); antepartum or intrapartum haemorrhage; known or suspected intrauterine growth retardation; any known or suspected fetal medical complication; abnormal Doppler artery velocimetry; known fetal malformation; poor obstetric history (e.g. history of stillbirth); un‐booked.
Participants randomised: 582 women randomised (298 admission CTG, 284 intermittent auscultation).

Randomisation on admission in labour.

Interventions

Admission CTG: a 15‐minute CTG on admission in spontaneous uncomplicated labour.

Intermittent auscultation: auscultation of the fetal heart for one continuous minute using a Pinard stethoscope or Doppler ultrasound device, after a contraction, at least every 15 minutes in the first stage of labour, and every 5 minutes in the second stage of labour.

Outcomes

Outcomes considered in the review and reported in or extracted from the study:

  • caesarean section;

  • instrumental vaginal birth;

  • oxytocin for augmentation of labour;

  • fetal and neonatal deaths;

  • Apgar score < 7 at or after 5 minutes;

  • admission to neonatal intensive care.

Notes

See Participants.

The study was funded by Buckinghamshire Hospitals NHS Trust's Research Department and through the establishment of a research midwife role within the maternity unit.

Declaration of interest not mentioned.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"...via a random number table."

Allocation concealment (selection bias)

Low risk

"Allocation to control and experimental arms was via opening of the next envelope in a series of sequentially numbered envelopes."

Blinding of participants and personnel (performance bias)
All outcomes

High risk

Although not documented, we judged, given nature of intervention, that women and clinicians were not blind to the interventions used.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Not stated.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All outcome data reported with exception of "augmentation with oxytocin" where missing data were low (admission CTG N = 2, 0.7% and intermittent auscultation N = 4, 1.4%).

Selective reporting (reporting bias)

Low risk

All outcomes stated in the methods section were reported adequately in results.

Other bias

Low risk

None identified.

BD: base deficit
BD/E: base deficit/excess
CTG: cardiotocograph
EFM: electronic fetal monitoring
FHR: fetal heart rate
RCT: randomised controlled trial

Characteristics of ongoing studies [ordered by study ID]

Devane 2008

Trial name or title

Foetal cardiotocography versus intermittent auscultation during labour ward admission: a randomised controlled trial (the ADCAR trial)

Methods

RCT

Participants

  1. Women between 37 + 0 and 40 + 6 completed weeks of pregnancy.

  2. Absence of antenatal, maternal and fetal risk factors to the development of neonatal encephalopathy, cerebral palsy or perinatal death as per Royal College of Obstetricians and Gynaecologists (2001), which warrant EFM.

  3. Aged greater than or equal to 18 years.

  4. Ability to understand study information and willingness to give written, informed consent.

  5. Women participating in interviews must be able to converse in English

Interventions

  1. Control: 20‐minute CTG on admission to labour ward/assessment room with signs of labour.

  2. Intervention: intermittent auscultation of the fetal heart, on admission to the labour ward/assessment room with signs of labour, using a Pinard stethoscope or a Doppler ultrasound device

Outcomes

Primary: incidence of caesarean section

Starting date

2008

Contact information

Declan Devane

[email protected]

Notes

CTG: cardiotocograph
EFM: electronic fetal monitoring
RCT: randomised controlled trial

Data and analyses

Open in table viewer
Comparison 1. Admission cardiotocography versus Intermittent auscultation (low‐risk women)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Caesarean section Show forest plot

4

11338

Risk Ratio (M‐H, Random, 95% CI)

1.20 [1.00, 1.44]

Analysis 1.1

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 1 Caesarean section.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 1 Caesarean section.

2 Instrumental vaginal birth Show forest plot

4

11338

Risk Ratio (M‐H, Random, 95% CI)

1.10 [0.95, 1.27]

Analysis 1.2

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 2 Instrumental vaginal birth.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 2 Instrumental vaginal birth.

3 Continuous EFM during labour Show forest plot

3

10753

Risk Ratio (M‐H, Random, 95% CI)

1.30 [1.14, 1.48]

Analysis 1.3

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 3 Continuous EFM during labour.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 3 Continuous EFM during labour.

4 Amniotomy Show forest plot

2

2694

Risk Ratio (M‐H, Random, 95% CI)

1.04 [0.97, 1.12]

Analysis 1.4

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 4 Amniotomy.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 4 Amniotomy.

5 Oxytocin for augmentation of labour Show forest plot

4

11324

Risk Ratio (M‐H, Random, 95% CI)

1.05 [0.95, 1.17]

Analysis 1.5

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 5 Oxytocin for augmentation of labour.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 5 Oxytocin for augmentation of labour.

6 Epidural Show forest plot

3

10757

Risk Ratio (M‐H, Random, 95% CI)

1.11 [0.87, 1.41]

Analysis 1.6

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 6 Epidural.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 6 Epidural.

7 Fetal blood sampling Show forest plot

3

10757

Risk Ratio (M‐H, Random, 95% CI)

1.28 [1.13, 1.45]

Analysis 1.7

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 7 Fetal blood sampling.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 7 Fetal blood sampling.

8 Fetal and neonatal deaths Show forest plot

4

11339

Risk Ratio (M‐H, Random, 95% CI)

1.01 [0.30, 3.47]

Analysis 1.8

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 8 Fetal and neonatal deaths.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 8 Fetal and neonatal deaths.

9 Evidence of fetal multi‐organ compromise within the first 24 hours after birth Show forest plot

1

8056

Risk Ratio (M‐H, Random, 95% CI)

0.56 [0.19, 1.67]

Analysis 1.9

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 9 Evidence of fetal multi‐organ compromise within the first 24 hours after birth.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 9 Evidence of fetal multi‐organ compromise within the first 24 hours after birth.

10 Admission to neonatal intensive care Show forest plot

4

11331

Risk Ratio (M‐H, Random, 95% CI)

1.03 [0.86, 1.24]

Analysis 1.10

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 10 Admission to neonatal intensive care.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 10 Admission to neonatal intensive care.

11 Apgar score < 7 at or after 5 minutes Show forest plot

4

11324

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.54, 1.85]

Analysis 1.11

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 11 Apgar score < 7 at or after 5 minutes.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 11 Apgar score < 7 at or after 5 minutes.

12 Hypoxic ischaemic encephalopathy Show forest plot

1

2367

Risk Ratio (M‐H, Random, 95% CI)

1.19 [0.37, 3.90]

Analysis 1.12

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 12 Hypoxic ischaemic encephalopathy.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 12 Hypoxic ischaemic encephalopathy.

13 Neonatal seizures Show forest plot

1

8056

Risk Ratio (M‐H, Random, 95% CI)

0.72 [0.32, 1.61]

Analysis 1.13

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 13 Neonatal seizures.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 13 Neonatal seizures.

14 Length of stay in neonatal intensive care (days) Show forest plot

1

91

Mean Difference (IV, Random, 95% CI)

1.80 [‐0.59, 4.19]

Analysis 1.14

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 14 Length of stay in neonatal intensive care (days).

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 14 Length of stay in neonatal intensive care (days).

15 Length of stay in neonatal intensive care (hours) Show forest plot

1

318

Mean Difference (IV, Random, 95% CI)

6.20 [‐8.70, 21.10]

Analysis 1.15

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 15 Length of stay in neonatal intensive care (hours).

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 15 Length of stay in neonatal intensive care (hours).

Study flow diagram
Figuras y tablas -
Figure 1

Study flow diagram

Risk of bias summary: review authors' judgements about each risk of bias item for each included study
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 1 Caesarean section.
Figuras y tablas -
Analysis 1.1

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 1 Caesarean section.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 2 Instrumental vaginal birth.
Figuras y tablas -
Analysis 1.2

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 2 Instrumental vaginal birth.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 3 Continuous EFM during labour.
Figuras y tablas -
Analysis 1.3

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 3 Continuous EFM during labour.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 4 Amniotomy.
Figuras y tablas -
Analysis 1.4

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 4 Amniotomy.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 5 Oxytocin for augmentation of labour.
Figuras y tablas -
Analysis 1.5

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 5 Oxytocin for augmentation of labour.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 6 Epidural.
Figuras y tablas -
Analysis 1.6

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 6 Epidural.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 7 Fetal blood sampling.
Figuras y tablas -
Analysis 1.7

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 7 Fetal blood sampling.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 8 Fetal and neonatal deaths.
Figuras y tablas -
Analysis 1.8

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 8 Fetal and neonatal deaths.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 9 Evidence of fetal multi‐organ compromise within the first 24 hours after birth.
Figuras y tablas -
Analysis 1.9

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 9 Evidence of fetal multi‐organ compromise within the first 24 hours after birth.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 10 Admission to neonatal intensive care.
Figuras y tablas -
Analysis 1.10

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 10 Admission to neonatal intensive care.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 11 Apgar score < 7 at or after 5 minutes.
Figuras y tablas -
Analysis 1.11

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 11 Apgar score < 7 at or after 5 minutes.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 12 Hypoxic ischaemic encephalopathy.
Figuras y tablas -
Analysis 1.12

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 12 Hypoxic ischaemic encephalopathy.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 13 Neonatal seizures.
Figuras y tablas -
Analysis 1.13

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 13 Neonatal seizures.

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 14 Length of stay in neonatal intensive care (days).
Figuras y tablas -
Analysis 1.14

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 14 Length of stay in neonatal intensive care (days).

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 15 Length of stay in neonatal intensive care (hours).
Figuras y tablas -
Analysis 1.15

Comparison 1 Admission cardiotocography versus Intermittent auscultation (low‐risk women), Outcome 15 Length of stay in neonatal intensive care (hours).

Summary of findings for the main comparison. Admission cardiotocography compared to Intermittent auscultation (low‐risk women) for assessment of fetal wellbeing

Admission cardiotocography compared to Intermittent auscultation (low‐risk women) for assessment of fetal wellbeing

Patient or population: Low risk pregnant women. All of the women were in labour.
Setting: Ireland and UK
Intervention: Admission cardiotocography ‐ women received a routine 15‐minute (1 trial) or 20‐minute (3 trials) tracing.
Comparison: Intermittent auscultation (low‐risk women) ‐ women received intermittent auscultation of the fetal heart for at least one full minute (4 trials), during and after a contraction (2 trials) or after a contraction only (2 trials).

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Risk with Intermittent auscultation (low‐risk women)

Risk with admission cardiotocography

Incidence of caesarean section

Study population

RR 1.20
(1.00 to 1.44)

11338
(4 RCTs)

⊕⊕⊕⊝
MODERATE 1 2

36 per 1000

44 per 1000
(36 to 52)

Incidence of operative vaginal birth

Study population

RR 1.10
(0.95 to 1.27)

11338
(4 RCTs)

⊕⊕⊝⊝
LOW 1 3

126 per 1000

139 per 1000
(120 to 160)

Perinatal mortality rate (fetal and neonatal deaths excluding lethal congenital anomalies)

Study population

RR 1.01
(0.30 to 3.47)

11339
(4 RCTs)

⊕⊕⊕⊝
MODERATE 4 5 6

1 per 1000

1 per 1000
(0 to 3)

Severe neurodevelopmental disability assessed ≥ 12 months of age

Study population

(0 RCTs)

None of the included studies reported data for the outcome

see comment

see comment

Incidence of continuous electronic fetal monitoring during labour

Study population

RR 1.30
(1.14 to 1.48)

10753
(3 RCTs)

⊕⊕⊝⊝
LOW 1 7

417 per 1000

542 per 1000
(475 to 617)

Incidence and severity of hypoxic ischaemic encephalopathy (incidence only reported)

Study population

RR 1.19
(0.37 to 3.90)

2367
(1 RCT)

⊕⊝⊝⊝
VERY LOW 1 8

4 per 1000

5 per 1000
(2 to 17)

Incidence of seizures in the neonatal period

Study population

RR 0.72
(0.32 to 1.61)

8056
(1 RCT)

⊕⊕⊝⊝
LOW 1 9

3 per 1000

2 per 1000
(1 to 6)

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Most studies contributing data had design limitations: outcome may have been affected by lack of blinding as all studies judged to be at high risk of performance bias (‐1)

2 Good sample size (> 3000), no measurable heterogeneity (I² = 0%), however 95% confidence interval touches the line of no effect (not downgraded)

3 Good sample size (> 3000), though wide confidence intervals cross the line of no effect (‐1)

4 Studies contributing data had design limitations: unlikely this outcome was affected by lack of blinding (not downgraded)

5 Few events but good sample size (not downgraded)

6 Very wide confidence intervals crossing the line of no effect (‐1)

7 Statistical heterogeneity (I² = 79%) (‐1)

8 Wide confidence interval crossing the line of no effect, few events & small sample size (based on one study) (‐2)

9 Wide confidence intervals crossing the line of no effect, large sample size with data from one study (‐1)

Figuras y tablas -
Summary of findings for the main comparison. Admission cardiotocography compared to Intermittent auscultation (low‐risk women) for assessment of fetal wellbeing
Comparison 1. Admission cardiotocography versus Intermittent auscultation (low‐risk women)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Caesarean section Show forest plot

4

11338

Risk Ratio (M‐H, Random, 95% CI)

1.20 [1.00, 1.44]

2 Instrumental vaginal birth Show forest plot

4

11338

Risk Ratio (M‐H, Random, 95% CI)

1.10 [0.95, 1.27]

3 Continuous EFM during labour Show forest plot

3

10753

Risk Ratio (M‐H, Random, 95% CI)

1.30 [1.14, 1.48]

4 Amniotomy Show forest plot

2

2694

Risk Ratio (M‐H, Random, 95% CI)

1.04 [0.97, 1.12]

5 Oxytocin for augmentation of labour Show forest plot

4

11324

Risk Ratio (M‐H, Random, 95% CI)

1.05 [0.95, 1.17]

6 Epidural Show forest plot

3

10757

Risk Ratio (M‐H, Random, 95% CI)

1.11 [0.87, 1.41]

7 Fetal blood sampling Show forest plot

3

10757

Risk Ratio (M‐H, Random, 95% CI)

1.28 [1.13, 1.45]

8 Fetal and neonatal deaths Show forest plot

4

11339

Risk Ratio (M‐H, Random, 95% CI)

1.01 [0.30, 3.47]

9 Evidence of fetal multi‐organ compromise within the first 24 hours after birth Show forest plot

1

8056

Risk Ratio (M‐H, Random, 95% CI)

0.56 [0.19, 1.67]

10 Admission to neonatal intensive care Show forest plot

4

11331

Risk Ratio (M‐H, Random, 95% CI)

1.03 [0.86, 1.24]

11 Apgar score < 7 at or after 5 minutes Show forest plot

4

11324

Risk Ratio (M‐H, Random, 95% CI)

1.00 [0.54, 1.85]

12 Hypoxic ischaemic encephalopathy Show forest plot

1

2367

Risk Ratio (M‐H, Random, 95% CI)

1.19 [0.37, 3.90]

13 Neonatal seizures Show forest plot

1

8056

Risk Ratio (M‐H, Random, 95% CI)

0.72 [0.32, 1.61]

14 Length of stay in neonatal intensive care (days) Show forest plot

1

91

Mean Difference (IV, Random, 95% CI)

1.80 [‐0.59, 4.19]

15 Length of stay in neonatal intensive care (hours) Show forest plot

1

318

Mean Difference (IV, Random, 95% CI)

6.20 [‐8.70, 21.10]

Figuras y tablas -
Comparison 1. Admission cardiotocography versus Intermittent auscultation (low‐risk women)